Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 516 | nsp3:L516I; | CL-3e; |
| 538 | nsp3:L538-; | CL-3d;CL-3e; |
| 550 | nsp3:L550I; | CL-3b;CL-3e; |
| 557 | nsp3:L557F; | CL-1a;CL-1a_2;CL-2; |
| 557 | nsp3:L557W; | CL-3c; |
| 561 | nsp3:L561F; | CL-1a_3b; |
| 561 | nsp3:L561I; | CL-3e; |
| 616 | nsp3:L616-; | CL-3c; |
| 620 | nsp3:L620F; | CL-3b;CL-3d;CL-3e; |
| 623 | nsp3:L623I; | CL-3c;CL-4; |
| 639 | nsp3:L639-; | CL-3e; |
| 65 | nsp3:L65-; | CL-3e; |
| 65 | nsp3:L65F; | CL-3b;CL-3f; |
| 672 | nsp3:L672V; | CL-3f; |
| 710 | nsp3:L710F; | CL-3e; |
| 710 | nsp3:L710I; | CL-3d; |
| 72 | nsp3:L72-; | CL-3b;CL-3e; |
| 728 | nsp3:L728-; | CL-1a_3b;CL-3b;CL-3c;CL-3e; |
| 728 | nsp3:L728I; | CL-1a_3b;CL-3e; |
| 72 | nsp3:L72I; | CL-3e; |
| 738 | nsp3:L738-; | CL-2;CL-3e; |
| 738 | nsp3:L738I; | CL-3d; |
| 738 | nsp3:L738P; | CL-5; |
| 741 | nsp3:L741F; | CL-3c;CL-3d;CL-3e; |
| 741 | nsp3:L741I; | CL-3c; |
| 741 | nsp3:L741R; | CL-3e; |
| 742 | nsp3:L742-; | CL-3b;CL-3f; |
| 742 | nsp3:L742F; | CL-3f; |
| 744 | nsp3:L744-; | CL-3b;CL-3e; |
| 75 | nsp3:L75-; | CL-3b;CL-3c;CL-3e; |
| 75 | nsp3:L75M; | CL-3e; |
| 75 | nsp3:L75Q; | CL-3e;CL-3f; |
| 761 | nsp3:L761-; | CL-3b;CL-3e; |
| 761 | nsp3:L761I; | CL-1a_3e;CL-3b; |
| 781 | nsp3:L781-; | CL-3e; |
| 781 | nsp3:L781F; | CL-1a_2;CL-2; |
| 79 | nsp3:L79-; | CL-1a_3e;CL-3e; |
| 79 | nsp3:L79F; | CL-1b; |
| 79 | nsp3:L79I; | CL-3e; |
| 803 | nsp3:L803I; | CL-3e; |
| 825 | nsp3:L825-; | CL-3b;CL-3e;CL-3f; |
| 825 | nsp3:L825M; | CL-3e; |
| 846 | nsp3:L846-; | CL-1b;CL-3b;CL-3d;CL-3e;CL-3f; |
| 858 | nsp3:L858-; | CL-3b;CL-3c; |
| 865 | nsp3:L865-; | CL-3b; |
| 865 | nsp3:L865F; | CL-3d;CL-3e; |
| 865 | nsp3:L865I; | CL-3e; |
| 870 | nsp3:L870-; | CL-3e; |
| 870 | nsp3:L870V; | CL-3e; |
| 877 | nsp3:L877-; | CL-3b;CL-3c;CL-3e; |
Page 281 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com